Pacific Biosciences of California, Inc. Increase (Decrease) in Other Operating Liabilities
Pacific Biosciences of California, Inc. (PACB) reported Increase (Decrease) in Other Operating Liabilities of $5.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $734.00K.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $5.13M, a 118.76% increase year-over-year.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $1.03M, a 57.97% decline year-over-year.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$1.59M.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$1.19M.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$4.61M, a 288.32% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $2.45M, a 176.10% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $887.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $734.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.87M 10-Q · filed 2026-08-06 | $6.89M derived: sum of 3 quarters · filed 2026-08-06 | $5.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $5.13M 10-Q · filed 2026-05-08 | $6.16M derived: sum of 2 quarters · filed 2026-05-08 | $4.57M derived: sum of 3 quarters · filed 2026-05-08 | $1.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$561.00K derived: sum of 2 quarters · filed 2026-02-25 | -$3.54M derived: sum of 3 quarters · filed 2026-08-06 | -$1.19M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.57M derived: sum of 2 quarters · filed 2026-08-06 | -$2.22M 10-Q · filed 2025-11-06 | $222.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$632.00K 10-Q · filed 2026-08-06 | $1.81M derived: sum of 3 quarters · filed 2026-08-06 | -$4.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.35M 10-Q · filed 2026-05-08 | $4.79M derived: sum of 2 quarters · filed 2026-05-08 | -$1.18M derived: sum of 3 quarters · filed 2026-05-08 | $2.89M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.52M derived: sum of 2 quarters · filed 2026-02-25 | $540.00K derived: sum of 3 quarters · filed 2026-02-25 | -$4.61M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.90M derived: sum of 2 quarters · filed 2025-11-06 | -$7.05M 10-Q · filed 2025-11-06 | -$3.46M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.09M 10-Q · filed 2025-08-07 | $2.51M derived: sum of 3 quarters · filed 2026-02-25 | $821.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$5.15M 10-Q · filed 2025-05-12 | -$1.56M derived: sum of 2 quarters · filed 2026-02-25 | -$3.24M derived: sum of 3 quarters · filed 2026-02-25 | -$248.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.91M derived: sum of 2 quarters · filed 2026-02-25 | $4.90M derived: sum of 3 quarters · filed 2026-02-25 | $2.45M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.31M derived: sum of 2 quarters · filed 2024-11-12 | -$1.15M 10-Q · filed 2024-11-12 | $1.44M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $539.00K 10-Q · filed 2024-08-09 | $3.13M derived: sum of 3 quarters · filed 2025-03-17 | $1.05M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | -$2.46M 10-Q · filed 2024-05-09 | $132.00K derived: sum of 2 quarters · filed 2025-03-17 | -$1.95M derived: sum of 3 quarters · filed 2025-03-17 | $944.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $508.00K derived: sum of 2 quarters · filed 2025-03-17 | $3.40M derived: sum of 3 quarters · filed 2025-03-17 | $887.00K 10-K · filed 2025-03-17 |
| 2022-09-30 | -$2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $812.00K derived: sum of 2 quarters · filed 2023-11-03 | -$1.70M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $379.00K 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | -$2.51M 10-Q · filed 2023-05-04 | |||
| 2014-03-31 | -$320.00K 10-Q · filed 2014-05-08 | -$630.00K derived: sum of 2 quarters · filed 2014-05-08 | -$936.00K derived: sum of 3 quarters · filed 2014-05-08 | -$1.24M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-12-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$616.00K derived: sum of 2 quarters · filed 2014-03-14 | -$916.00K derived: sum of 3 quarters · filed 2014-03-14 | -$1.20M 10-K · filed 2014-03-14 |
| 2013-09-30 | -$306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$606.00K derived: sum of 2 quarters · filed 2013-11-12 | -$894.00K 10-Q · filed 2013-11-12 | -$1.17M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$588.00K 10-Q · filed 2013-08-09 | -$867.00K derived: sum of 3 quarters · filed 2014-05-08 | -$1.14M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-03-31 | -$288.00K 10-Q · filed 2014-05-08 | -$567.00K derived: sum of 2 quarters · filed 2014-05-08 | -$835.00K derived: sum of 3 quarters · filed 2014-05-08 | -$1.10M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | -$279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$547.00K derived: sum of 2 quarters · filed 2014-03-14 | -$813.00K derived: sum of 3 quarters · filed 2014-03-14 | -$1.07M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$534.00K derived: sum of 2 quarters · filed 2013-11-12 | -$791.00K 10-Q · filed 2013-11-12 | -$1.07M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | -$266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$523.00K 10-Q · filed 2013-08-09 | -$800.00K derived: sum of 3 quarters · filed 2014-03-14 | -$1.08M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$257.00K 10-Q · filed 2013-05-10 | -$534.00K derived: sum of 2 quarters · filed 2014-03-14 | -$812.00K derived: sum of 3 quarters · filed 2014-03-14 | -$128.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | -$277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$555.00K derived: sum of 2 quarters · filed 2014-03-14 | $129.00K derived: sum of 3 quarters · filed 2014-03-14 | $850.00K 10-K · filed 2014-03-14 |
| 2011-09-30 | -$278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $406.00K derived: sum of 2 quarters · filed 2012-11-01 | $1.13M 10-Q · filed 2012-11-01 | $1.73M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $684.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.41M 10-Q · filed 2012-08-07 | $2.00M derived: sum of 3 quarters · filed 2013-03-15 | $1.93M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $721.00K 10-Q · filed 2012-05-07 | $1.32M derived: sum of 2 quarters · filed 2013-03-15 | $1.24M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $599.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $521.00K derived: sum of 2 quarters · filed 2013-03-15 | $299.00K 10-K · filed 2013-03-15 | |
| 2010-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$300.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$222.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | -$92.00K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |